Discontinuation of teriflunomide and dimethyl fumarate in a large Italian multicentre population: a 24-month real-world experience

Background Teriflunomide (TRF) and Dimethyl fumarate (DMF) are licensed drugs for relapsing-remitting Multiple Sclerosis (RRMS). Objectives We aimed to compare the rate and the time to discontinuation among persons with RRMS (pwRRMS), newly treated with TRF and DMF. Materials and methods A retrospec...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of neurology Jg. 266; H. 2; S. 411 - 416
Hauptverfasser:	D’Amico, E., Zanghì, A., Sciandra, M., Borriello, G., Callari, G., Gallo, A., Salemi, G., Cottone, S., Buccafusca, M., Valentino, P., Bossio, R. B., Grimaldi, L. M. E., Pozzilli, C., Tedeschi, G., Zappia, M., Patti, F.
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	Berlin/Heidelberg Springer Berlin Heidelberg 01.02.2019 Springer Nature B.V
Schlagworte:	Magnetic resonance imaging Medicine Medicine & Public Health Multiple sclerosis Neurology Neuroradiology Neurosciences Original Communication Population Teriflunomide Discontinuation rate Multiple sclerosis Real-life Dimethyl fumarate
ISSN:	0340-5354, 1432-1459, 1432-1459
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!